Louisville, KY, United States of America

George R Aronoff

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University Of Louisville Research Foundation, Inc.. Active years: 2017-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: George R Aronoff: Innovator in Personalized Pharmacologic Dosing

Introduction

George R Aronoff is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of pharmacology, particularly in the area of personalized dosing of pharmacologic agents. With a total of 3 patents to his name, Aronoff's work is paving the way for advancements in patient-specific medication management.

Latest Patents

One of Aronoff's latest patents is titled "System and method for personalized dosing of pharmacologic agents." This innovative system includes executing, using a processing device, a plurality of dosing regimen program modules to determine a respective plurality of dose sets in response to receiving, from an input device, a target response value for a patient. Additionally, it involves executing a dosing selection algorithm module to determine a recommended dose set computed as a combination of the plurality of dose sets weighted by degrees of matching computed using fuzzy sets and the response profile.

Career Highlights

Aronoff is affiliated with the University of Louisville Research Foundation, Inc., where he continues to contribute to research and development in pharmacology. His work focuses on enhancing the precision of medication dosing, which is crucial for improving patient outcomes.

Collaborations

Throughout his career, Aronoff has collaborated with esteemed colleagues, including Adam E Gaweda and Alfred A Jacobs. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

George R Aronoff's contributions to personalized pharmacologic dosing exemplify the impact of innovation in healthcare. His patents and ongoing research are vital for the future of patient-centered medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…